Activation of blood coagulation and fibrinolysis in Graves' disease. 1991

F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
Institute of Internal Medicine, University of Cagliari, Italy.

We studied blood coagulation and fibrinolysis activities in hyperthyroidism before and after methimazole or 131I. Fibrinopeptide A and B beta 15-42, in vivo indicators of thrombin and plasmin activity, were measured by RIA, while fibrinogen by the Clauss method. We studied 50 patients, affected by toxic diffuse goiter. We evaluated 21 of them before and after treatment. Fibrinogen, fibrinopeptide A, and B beta 15-42 were higher in patients than in controls (p less than 0.0001). There was no difference in fibrinopeptide A nor in B beta 15-42 before or after treatment. In euthyroidism fibrinogen returned to normal values. Inflammation of the thyroid gland secondary to autoimmunity may activate blood coagulation by release of tissue factor. High fibrinogen before treatment may be explained as an aspecific response. Since it persists in euthyroidism, autoimmunity could account for high fibrinopeptide A and B beta 15-42 aftertreatment.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses

Related Publications

F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
January 1980, Postepy higieny i medycyny doswiadczalnej,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
January 1991, International archives of occupational and environmental health,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
April 1976, Thrombosis and haemostasis,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
July 1980, Nature,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
April 1963, Lancet (London, England),
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
January 1994, Rinsho byori. The Japanese journal of clinical pathology,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
February 1971, Angewandte Chemie (International ed. in English),
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
January 1993, Zeitschrift fur Kardiologie,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
September 1973, Nihon rinsho. Japanese journal of clinical medicine,
F Marongiu, and M Conti, and M L Murtas, and G Mameli, and G G Sorano, and E Martino
May 1974, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!